Przegląd Dermatologiczny

Pełna treść

4/2026 vol. 113
Opis przypadku

A Unique Overlap Syndrome Involving Systemic Sclerosis, Systemic Lupus Erythematosus, and ANCA-associated vasculitis

  1. Clinical Department of Rheumatology, Immunology and Internal Medicine, University Hospital in Krakow, Poland

  2. Doctoral School of Medical and Health Sciences, Jagiellonian University Medical College, Krakow, Poland

  3. Department of Hematology, Jagiellonian University Medical College, Krakow, Poland

  4. Department of Rheumatology and Immunology, Jagiellonian University Medical College, Krakow, Poland

Dermatol Rev/Przegl Dermatol 2026, 113, 240–243

Data publikacji online: 2026/11/16
Plik artykułu
A Unique Overlap.pdf
  1. Pakozdi A., Nihtyanova S., Moinzadeh P., Ong V.H., Black C.M., Denton C.P.: Clinical and serological hallmarks of systemic sclerosis overlap syndromes. J Rheumatol 2011, 38, 2406-2409.
  2. Clark K.E.N.: Review of systemic sclerosis and antineutrophil cytoplasmic antibody vasculitis overlap: using autoantibodies for a personalised medicine approach. J Scleroderma Relat Disord 2023, 8, 7-13.
  3. Bajema I.M., Wilhelmus S., Alpers C.E., Bruijn J.A., Colvin R.B., Cook H.T., et al.: Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices. Kidney Int 2018, 93, 789-796.
  4. Wach A., Korkosz M., Okoń K., Kosałka-Węgiel J.: A case of systemic lupus erythematosus with antineutrophil cytoplasmic antibodies-positive skin vasculitis and concomitant combined thrombophilia. Pol Arch Intern Med 2024, 134, 16810.
  5. Hughes M., Kahaleh B., Denton C.P., Mason J.C., Matucci-Cerinic M.: ANCA in systemic sclerosis, when vasculitis overlaps with vasculopathy: a devastating combination of pathologies. Rheumatology 2021, 60, 5509-5516.
  6. Ha J.W., Pyo J.Y., Ahn S.S., Song J.J., Park Y.B., Lee S.W.: Overlap syndrome of systemic sclerosis with antineutrophil cytoplasmic antibody-associated vasculitis according to 2022 ACR/EULAR criteria. Korean J Intern Med 2024, 39, 524-536.
  7. Jarrot P.A., Chiche L., Hervier B., Daniel L., Vuiblet V., Bardin N., et al.: Systemic lupus erythematosus and antineutrophil cytoplasmic antibody-associated vasculitis overlap syndrome in patients with biopsy-proven glomerulonephritis. Medicine 2016, 95, e3748.
  8. Moxey J., Huq M., Proudman S., Sahhar J., Ngian G.S., Walker J., et al.: Significance of anti-neutrophil cytoplasmic antibodies in systemic sclerosis. Arthritis Res Ther 2019, 21, 57.
  9. Arad U., Balbir-Gurman A., Doenyas-Barak K., Amit-Vazina M., Caspi D., Elkayam O.: Anti-neutrophil antibody associated vasculitis in systemic sclerosis. Semin Arthritis Rheum 2011, 41, 223-229.
  10. Felten R., Nespola B., Chatelus E., Arnaud L., Gottenberg J.E., Canuet M., et al.: Acute renal failure in systemic sclerosis revealing Goodpasture syndrome: “All that glitters is not scleroderma renal crisis”. J Scleroderma Relat Disord 2020, 5, NP1–NP5.
Copyright: © 2026 Polish Dermatological Association. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Udostępnij
without publication fees
without publication fees